3 active not recruiting, 3 recruiting, 1 terminated. 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Active not recruiting 3, Recruiting 3, Terminated 1 |
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Fludeoxyglucose (18f): new trials by email Literature Review of Fludeoxyglucose (18f) trials Research Report on Fludeoxyglucose (18f)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma | Phase 2 / Phase 3 | Terminated | Children's Oncology Group | 2 | 2025-11-10 | 2026-10-05 |
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Biospecimen Collection, Bleomycin Sulfate, Brentuximab Vedotin - Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 | Phase 3 | Recruiting | National Cancer Institute (NCI) | 1875 | 2023-05-11 | 2026-11-03 |
| Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer Chest Radiography, Computed Tomography, Fludeoxyglucose F-18 - Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma | Phase 2 / Phase 3 | Recruiting | NRG Oncology | 686 | 2020-09-23 | 2026-08-17 |
| Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer Atezolizumab, Biospecimen Collection, Computed Tomography - Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 417 | 2020-08-13 | 2026-10-27 |
| A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations Allogeneic Hematopoietic Stem Cell Transplantation, Asparaginase Erwinia chrysanthemi, Biospecimen Collection - Acute Myeloid Leukemia | Phase 3 | Recruiting | Children's Oncology Group | 1400 | 2020-07-21 | 2026-09-17 |
| De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Biopsy Procedure, Biospecimen Collection, Cisplatin - Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 384 | 2019-10-09 | 2026-07-02 |
| Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer Biospecimen Collection, Cisplatin, Computed Tomography - Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 636 | 2019-08-16 | 2026-10-26 |
Oropharyngeal Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Leukemia, Myeloid, Acute (1) · Lung Neoplasms (1) · Mouth Neoplasms (1) · Sarcoma, Ewing (1)
National Cancer Institute (NCI) (4) · Children's Oncology Group (2) · NRG Oncology (1)
United States (7) · Canada (4) · Puerto Rico (2) · Australia (1)
Bhuvana A Setty (1) · Kara M Kelly (1) · Megan E Daly (1) · Nabil F Saba (1) · Stephen Y Lai (1) · Sue S Yom (1) · Todd M Cooper (1)
PMID 33843815, PMID 37505794, PMID 38107263, PMID 38947228, PMID 42497367, PMID 42702214
U10CA180886 (3), U10CA180868 (2), U10CA180820 (1), U10CA180888 (1)